Hot Flash Medication May Combat Breast Cancer Cells
New research suggests common treatments for menopausal symptoms could help suppress cancer cell growth.
Updated on Oct. 20, 2026 in Cancer
Live Poll
Do you believe new research into existing medications is a promising way to develop cancer treatments?
Researchers have discovered that neurokinin receptor antagonists, currently used for menopausal hot flashes, may reduce breast cancer cell invasiveness. The findings indicate these drugs can downregulate pathways that promote cancer cell viability.
Why it matters
The study explores whether existing treatments for menopausal symptoms could provide secondary benefits in oncology by targeting signaling pathways in breast tissue. This could potentially bridge the gap between symptom management and cancer therapeutics.
Immunohistochemical analysis shows neurokinin receptors are significantly over-expressed in cancerous breast tissue. In vitro tests confirmed these antagonists downregulate oncogenic pathways and reduce breast cancer cell viability.
The players
The Menopause Society
This is a non-profit organization focused on the health and quality of life of women during menopause and beyond.
The details
By using in-silico modeling and immunohistochemical analysis, researchers determined that neurokinin receptor signaling plays a role in breast cancer progression. The team found that targeting these receptors reduces the invasiveness of human breast cancer cells.
Timeline
October 20-24, 2026: The Menopause Society Annual Meeting takes place.
The Big Picture
The study findings will be presented at The Menopause Society 2026 Annual Meeting. This research follows a pattern of investigating the dual-purpose potential of existing pharmaceuticals to address complex cancer pathways.
Patients currently taking neurokinin receptor antagonists for menopausal symptoms should note that this study is experimental and focused on cellular mechanisms. It does not currently change existing treatment protocols for breast cancer or menopausal care.
The takeaway
This discovery highlights the potential for drug repurposing to provide novel solutions in cancer treatment. Patients should consult with their healthcare providers regarding any new medical developments before making changes to their health routines.
What happens next
The research findings are scheduled to be presented at The Menopause Society 2026 Annual Meeting, occurring from October 20-24, 2026, in San Diego.
Further reading
Learn more about the latest research in this field at the Cancer section.
Live Poll
Do you believe new research into existing medications is a promising way to develop cancer treatments?
